+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The effect of intravenous immunoglobulin on lymphocyte populations and activation markers in kawasaki syndrome



The effect of intravenous immunoglobulin on lymphocyte populations and activation markers in kawasaki syndrome



Arthritis & Rheumatism 34(9 SUPPL): S121




(PDF emailed within 1 workday: $29.90)

Accession: 033776596

Download citation: RISBibTeXText


Related references

The effect of intravenous immunoglobulin on lymphocyte populations in children with Kawasaki syndrome. Clinical and Experimental Rheumatology 10(6): 617-620, 1992

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. Journal of Clinical Investigation 79(2): 468-472, 1987

Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease. Acta Paediatrica 90(6): 623-627, June, 2001

The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease. Journal of Pediatrics 178(): 281-284.E1, 2016

Correlates of Defaulting from MDT among Leprosy Patients. Indian Journal of Leprosy 87(4): 241-248, 2018

Immunoglobulin ig allotypic markers in kawasaki disease kd studies in racially diverse populations. Pediatric Research 27(4 PART 2): 183A, 1990

Intravenous immunoglobulin in Kawasaki syndrome: a progress report. Pediatric Infectious Disease 5(3 Suppl): S211-S215, 1986

Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. Journal of Pediatrics 163(2): 521-526, 2013

Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease. Clinical Immunology 171: 25-31, 2016

Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers. Lupus 9(1): 26-32, 2000

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome. Pediatric Dermatology 30(3): E30-E31, 2014

IL-1, IL-6 and TNFa activity in children with Kawasaki syndrome before and after treating with intravenous immunoglobulin. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 434, 1995

Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome. Pediatric Infectious Disease Journal 17(11): 1054-1056, 1998

Effects of intravenous immunoglobulin upon the overexpression and over-activation of nuclear factor-κB and matrix metalloproteinase-9 in murine model of Kawasaki disease. Zhonghua Yi Xue Za Zhi 94(12): 938-943, 2015